Sun Pharmaceutical Industries Limited has entered into an exclusive licensing agreement with a subsidiary of Chinese pharma major China Medical System Holdings (CMS) to develop and commercialise Cyclosporine A 0.09 per cent eye drops and Tildrakizumab a medication for psoriasis and psoriatic arthritis in Greater China.

KIOCL has signed memorandum of understandings (MoUs) with Glencore International AG and Steel Mont GMBH. The shares of the company rose by almost 16 per cent intraday.

The hydrocarbon engineering division of L&T has been awarded twin orders from ONGC. The company has categorised the order as large order, which mean the order value is between Rs. 2,000 to Rs. 5,000 crore.

Ahead of the expiry of derivative contracts for the month of June, Nifty Auto was up 1.37 per cent, fuelled by a unanimous surge in auto stocks led by Tata Motors and M&M on Thursday. 

The stock of Emami Limited dipped more than 5 per cent on Thursday as the market was buzzing that the Emami Group is in exploratory talks with Ultratech Cement and private equity funds to sell stakes in its cement business, valuing it at Rs. 5,000-5,500 crore.

Following stocks are close to their 52-weeks low as at 2:39 p.m. on June 27, 2019.

The markets on June 27, 2019 opened gap up. BSE Sensex is trading at 39,671.10, up by 79.02 points and the Nifty is trading at 11,870.60, up by 23.05 points. 

Bangalore-based micro-credit finance company CreditAccess Grameen informed in a stock exchange filing that has completed transaction of Rs. 138.89 crore through Direct Assignment of portfolio loans, on Wednesday after market hours.

There are various ways in which you can have exposure to equities. One such way is investing in factor-based funds. So, what is this factor-based investing? Let’s find out.

Hybrid funds in the last one year have performed better than their equity counter parts and have largely generated positive returns, however, only few of them were able to beat their benchmarks.